"Once promoted as tools to address obesity as a medical issue, GLP-1 drugs are increasingly being seen *and marketed* as a way to look and feel better generally... Novo Nordisk, in particular, has leaned into the shift" via @statnews.com www.statnews.com/2026/09/28/g...
statnews.com
Once described as obesity medicines for 'patients,' GLP-1s are increasingly lifestyle drugs for 'customers'
Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own.